Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus

Summary

This study is being done to determine if pioglitazone (Actos) is helpful to patients with type 2 diabetes and could possibly prevent harmful consequences of cardiovascular disease in diabetic patients.

Timeline

Start

2007-06

Primary completion

—

Completion

2008-06

Outcome

Outcome not reported

Stopped: “This study was not conducted as the Principal Investigator left the institution”

Drugs

Indications